IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 133
Titolo Data di pubblicazione Autore(i) File
Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat 1-gen-2008 Celasco, Giuseppe; Moro, Luigi; Bozzella, Roberta; Mangano, KATIA DOMENICA; Quattrocchi, Cinzia; Aiello, Caterina; Donia, Marco; Fagone, Paolo; Di Marco, Roberto
The effects of the nitric oxide-modified HIV protease inhibitor Saquinavir-NO (Saq-NO) on p53-deficient androgen independent prostate cancer cell lines 1-gen-2010 Donia, Marco; Maksimovic Ivanic, Danijela; Mijatovic, Sanja; Mojic, Marija; Timotijevic, Gordana; Miljkovic, Djordje; Caponnetto, Salvatore; Fagone, Paolo; Libra, Massimo; Mangano, KATIA DOMENICA; Stosic Grujicic, Stanislava; Nicoletti, Ferdinando file da validare
The effects of the nitric oxide- modified HIV protease inhibitor Saquinavir-NO on p53- deficient androgen independent prostate cancer cell lines 1-gen-2010 Marco, Donia; DANIJELA MAKSIMOVIC IVANIC, ; Sanja, Mijatopvic; Marija, Mojic; Gordana, Timotijevic; Djordje, Milikovic; Salvatore, Caponnetto; Fagone, PAOLO FABRIZIO; Libra, Massimo; Mangano, KATIA DOMENICA; STANISLAVA STOSIC GRUJICIC, ; Nicoletti, Ferdinando file da validare
Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents 1-gen-2010 Donia, M; Mangano, KATIA DOMENICA; Quattrocchi, C; Fagone, P; Signorelli, Salvatore; Magro, Gaetano Giuseppe; Sfacteria, A; Bendtzen, K; Nicoletti, Ferdinando
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 1-gen-2011 Mangano, KATIA DOMENICA; Fagone, P; Quattrocchi, C; Colletti, G; Mammana, S; Di Marco, R; Nicoletti, F. file da validare
In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells 1-gen-2011 Donia, Marco; Maksimovic Ivanic, Danijela; Mijatovic, Sanja; Mojic, Marija; Miljkovic, Djordje; Timotijevic, Gordana; Fagone, Paolo; Caponnetto, Salvatore; Al Abed, Yousef; McCubrey James, A.; Stosic Grujicic, Stanislava; Nicoletti, Ferdinando
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 1-gen-2011 Fagone, P; Mangano, KATIA DOMENICA; Quattrocchi, C; Motterlini, R; DI MARCO, R; Magro, Gaetano Giuseppe; Penacho, N; Romao, Cc; Nicoletti, Ferdinando file da validare
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy 1-gen-2011 Steelman, Ls; Franklin, Ra; Abrams, Sl; Chappell, W; Kempf, Cr; Basecke, J; Stivala, F; Donia, M; Fagone, P; Nicoletti, Ferdinando; Libra, Massimo; Ruvolo, P; Ruvolo, V; Evangelisti, C; Martelli, Am; Mccubrey, Ja
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 1-gen-2011 Chappell, Wh; Steelman, Ls; Long, Jm; Kempf, Rc; Abrams, Sl; Franklin, Ra; Basecke, J; Stivala, F; Donia, M; Fagone, P; Malaponte, G; Mazzarino, Maria Clorinda; Nicoletti, Ferdinando; Libra, Massimo; Maksimovic Ivanic, D; Mijatovic, S; Montalto, G; Cervello, M; Laidler, P; Milella, M; Tafuri, A; Bonati, A; Evangelisti, C; Cocco, L; Martelli, Am; Mccubrey, Ja
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 1-gen-2011 Nicoletti, Alessandra; Fagone, P; Donzuso, G; Mangano, KATIA DOMENICA; Dibilio, V; Caponnetto, S; Bendtzen, K; Zappia, Mario; Nicoletti, Ferdinando
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 1-gen-2011 Steelman, Ls; Chappell, Wh; Abrams, Sl; Kempf, Cr; Long, J; Laidler, P; Mijatovic, S; Maksimovic Ivanic, D; Stivala, F; Mazzarino, Maria Clorinda; Donia, M; Fagone, P; Malaponte, G; Nicoletti, Ferdinando; Libra, Massimo; Milella, M; Tafuri, A; Bonati, A; Basecke, J; Cocco, L; Evangelisti, C; Martelli, Am; Montalto, G; Cervello, M; Mccubrey, Ja
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 1-gen-2011 Martelli, A. M.; Evangelisti, C.; Chappell, W.; Abrams, S. L.; Baesecke, J.; Stivala, F.; Donia, M.; Fagone, P.; Nicoletti, Ferdinando; Libra, Massimo; Ruvolo, V.; Ruvolo, P.; Kempf, C. R.; Steelman, L. S.; Mccubrey, J. A.
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 1-gen-2011 Donia, Marco; Anzaldi, Massimiliano; Di Marco, Roberto; Libra, Massimo; Mangano, KATIA DOMENICA; Fagone, Paolo; Galvagna, Salvatore; Di Gregorio, Pietro; Nicoletti, Ferdinando
mTOR as a multifunctional therapeutic target in HIV infection 1-gen-2011 Nicoletti, Ferdinando; Fagone, Paolo; Meroni, Pierluigi; Mccubrey, James; Bendtzen, Klaus
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 1-gen-2011 Steelman, Ls; Abrams, S; Chappell, Wh; Martelli, Am; Nicoletti, F; Fagone, P; Mazzarino, Maria Clorinda; Malaponte, G; Libra, Massimo; Stivala, F; Cervello, M; Mijatovic, S; Maksimovic Ivanic, D; Mccubrey, Ja file da validare
Novel approaches to target the prostate cancer stem cell - eliminating the root of the cancer 1-gen-2011 Mccubrey, Ja; Chappell, Wh; Abrams, S; Martelli, Am; Stivala, F; Nicoletti, Ferdinando; Fagone, P; Mazzarino, Maria Clorinda; Malaponte, G; Libra, Massimo; Cervello, M; Maksimovic Ivanic, D; Mijatovic, S; Steelman, Ls file da validare
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 1-gen-2011 Kosiewicz Michele, M.; Auci Dominick, L.; Fagone, Paolo; Mangano, KATIA DOMENICA; Caponnetto, Salvatore; Tucker Colleen, F.; Azeem, Nabeel; White Steven, K.; Frincke James, M.; Reading Christopher, L.; Nicoletti, Ferdinando
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 1-gen-2012 Mangano, KATIA DOMENICA; Fagone, P; Quattrocchi, C; Mammana, S; Di Rosa, M; Di Marco, R; Nicoletti, Ferdinando file da validare
Immune modifying capacity of new melanoma therapeutics with the potency to increase efficacy of Adoptive T-cell Therapy – potential synergism of combinations 1-gen-2012 Donia, M.; Hansen, M.; Sendrup, S. L.; Ellebaek, E.; Zeeberg Iversen, T.; Fagone, P.; Nicoletti, Ferdinando; Sick Andersen, R.; Høgdall, E.; Andersen, M. H.; thor Straten, P.; Svane, I. M. file da validare
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 1-gen-2012 Nicoletti, Ferdinando; Fagone, P.; Mangano, K.; Motterlini, R.; Meroni, P. L. file da validare
Mostrati risultati da 1 a 20 di 133
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile